Conditions will clinically be identified as (1) abnormal when AFP content is higher than 20.0 ng/mL, (2) suffering from cancer when 200.0 ng/mL AFP content lasts for 8 weeks, or (3) 400.00 ng/mL AFP concentration is sustained for 4 weeks. Here, AFP is linked to cancer.